Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value:
$408.27M
Total Bought:
$193.25M
Total Sold:
$110.77M
Net Transaction:
+$82.48M
Notable People:
Ronald Marc Panzier
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Apogee Therapeutics Inc374,000374,0000$28.23M$31.48M7.71%+$3.25M
Vor Biopharma Inc.(VOR)1,370,1071,750,000+379,893$17.92M$31.22M7.65%+$13.30M
Zura Bio LimitedCL A(ZURA)3,815,9304,215,930+400,000$20.00M$25.08M6.14%+$5.09M
Amylyx Pharmaceuticals, Inc.(AMLX)1,750,0001,750,0000$21.14M$24.32M5.96%+$3.19M
Nektar Therapeutics(NKTR)210,732316,453+105,721$8.91M$22.77M5.58%+$13.86M
Sol-Gel Technologies LtdSHS NEW
SHS NEW
0274,363+274,363$0$21.74M5.32%+$21.74M
Alumis Inc0856,061+856,061$0$18.86M4.62%+$18.86M
Bright Minds Biosciences Inc.(DRUG)0220,000+220,000$0$16.05M3.93%+$16.05M
Annexon, Inc.(ANNX)02,500,000+2,500,000$0$13.85M3.39%+$13.85M
Kalvista Pharmaceuticals Inc685,632675,000-10,632$11.07M$13.59M3.33%+$2.51M
Immunovant, Inc.(IMVT)750,000545,625-204,375$19.07M$13.55M3.32%-$5.51M
Jade Biosciences Inc806,273964,462+158,189$12.44M$13.55M3.32%+$1.11M
Contineum Therapeutics, Inc.CL A(CTNM)800,000800,198+198$9.14M$10.45M2.56%+$1.31M
Zenas BioPharma, Inc.(ZBIO)0524,066+524,066$0$10.25M2.51%+$10.25M
Neurogene Inc.(NGNE)350,000500,000+150,000$7.21M$10.08M2.47%+$2.87M
MoonLake ImmunotherapeuticsCL A(MLTX)0500,000+500,000$0$9.32M2.28%+$9.32M
Climb Bio, Inc.(CLYM)979,5341,334,130+354,596$3.92M$9.14M2.24%+$5.22M
Oruka Therapeutics, Inc.(ORKA)183,330183,3300$5.56M$8.99M2.20%+$3.44M
Eupraxia Pharmaceuticals Inc.(EPRX)1,200,0001,200,0000$9.06M$8.69M2.13%-$372.0K
Vera Therapeutics, Inc.CL A(VERA)0199,348+199,348$0$8.02M1.96%+$8.02M
Evommune, Inc.(EVMN)325,000325,0000$5.56M$7.47M1.83%+$1.91M
LB Pharmaceuticals Inc(LBRX)0300,000+300,000$0$7.40M1.81%+$7.40M
Compass Therapeutics, Inc.(CMPX)01,350,000+1,350,000$0$7.14M1.75%+$7.14M
SCYNEXIS, Inc.(SCYX)07,554,347+7,554,347$0$6.93M1.70%+$6.93M
Palisade Bio, Inc.(PALI)03,405,757+3,405,757$0$5.96M1.46%+$5.96M
Context Therapeutics Inc.(CNTX)4,683,7112,238,496-2,445,215$6.89M$5.86M1.44%-$1.02M
Relmada Therapeutics, Inc.(RLMD)0842,106+842,106$0$5.86M1.44%+$5.86M
Silence Therapeutics plcADS(SLN)808,0321,020,489+212,457$4.91M$5.38M1.32%+$465.1K
Unicycive Therapeutics, Inc.(UNCY)796,558796,5580$4.60M$5.24M1.28%+$645.2K
Tenax Therapeutics, Inc.(TENX)0327,307+327,307$0$5.23M1.28%+$5.23M
ProMIS Neurosciences, Inc.(PMN)0371,402+371,402$0$4.72M1.16%+$4.72M
Cullinan Therapeutics, Inc.(CGEM)634,032300,000-334,032$6.56M$4.26M1.04%-$2.30M
Immix Biopharma, Inc.(IMMX)0350,000+350,000$0$3.19M0.78%+$3.19M
Rezolute, Inc.(RZLT)951,809951,8090$2.25M$2.90M0.71%+$656.7K
Pharvaris N V
COM
82,80082,8000$2.30M$2.34M0.57%+$41.4K
Humacyte, Inc.(HUMA)03,750,000+3,750,000$0$2.28M0.56%+$2.28M
Avalo Therapeutics, Inc.(AVTX)124,666124,6660$2.26M$1.86M0.46%-$402.7K
Alkermes plcSHS(ALKS)050,000+50,000$0$1.77M0.43%+$1.77M
Opus Genetics, Inc.(IRD)0324,340+324,340$0$1.48M0.36%+$1.48M
Dianthus Therapeutics, Inc.(DNTH)350,0000-350,000$14.42M$0—-$14.42M
Disc Medicine, Inc.(IRON)250,0000-250,000$19.85M$0—-$19.85M
Fulcrum Therapeutics, Inc.(FULC)800,0000-800,000$9.05M$0—-$9.05M
Rapt Therapeutics Inc581,1870-581,187$19.68M$0—-$19.68M
Sana Biotechnology, Inc.(SANA)700,0000-700,000$2.85M$0—-$2.85M
Soleno Therapeutics Inc400,0000-400,000$18.52M$0—-$18.52M
Ultragenyx Pharmaceutical Inc.(RARE)300,0000-300,000$6.90M$0—-$6.90M
Upstream Bio, Inc.(UPB)300,0000-300,000$8.14M$0—-$8.14M
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q1 2026 | TickerTrail